HOME >> MEDICINE >> NEWS
U.S., Mexican scientific societies honor former Penn State professor

Research on steroid hormones cited as international landmark

Chemistry societies in the U.S. and Mexico join forces this month to honor a former Penn State professor for his landmark work to develop a cheaper way to mass produce the hormone progesterone. The work later led to the wide availability of such products as oral contraceptives and cortisone, a treatment for rheumatoid arthritis.

The American Chemical Society and the Mexican Chemical Society will designate the steroid work of Russell E. Marker and the development of the Mexican steroid industry as an International Historic Chemical Landmark. A plaque honoring this work will be presented October 1 at Penn State University's Pond Laboratory, where Marker taught and conducted his steroid research from 1934-1943.

Russell Marker's work and the proliferation of the Mexican steroid hormone industry drastically reduced the cost of progesterone, which helped make it more widely available. By the 1950s, over half of the sex hormones sold in the United States were produced in Mexico, and could be traced to synthetic techniques devised by Marker.

Another result of Russell Marker's work and the Mexican steroid industry was the development of the first oral contraceptive. Using some of Marker's methods, Carl Djerassi developed "the pill" in 1951 at Syntex, S.A. in Mexico.

In 1938, Marker proposed a new molecular structure of the plant steroid sarsasapogenin, isolated from sarsparilla. Marker manipulated this new structure using a chemical reaction sequence known as "degradation," to yield progesterone. This process of producing progesterone is now known as the Marker Degradation. Sarsasapogenin, however, was still an expensive starting material.

Marker embarked on an extensive search for a cheaper starting material that eventually led him to the Mexican state of Veracruz near Orizaba, home of a pl
'"/>

Contact: Ann Higgins
a_higgins@acs.org
202-872-274
American Chemical Society
30-Sep-1999


Page: 1 2

Related medicine news :

1. Sepsis on the increase in U.S., according to Emory University and CDC study
2. U.S., British scientific societies honor penicillin as International Chemical Landmark
3. Mexican Americans at greater risk for stroke than non-Hispanic whites
4. Cedars-Sinai researchers identify a gene that causes insulin resistance in Mexican Americans
5. Mexican-American stroke study shows differences
6. Mexican Americans more likely to die of heart disease than Caucasians
7. Scientific societies honor creation of the Mexican steroid hormone industry
8. Low Folate Levels In African American And Mexican American Adults
9. Public morally obliged to take part in scientific research, says leading ethicist
10. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
11. Can routine commercial cord blood banking be scientifically and ethically justified?

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mexican scientific societies honor former Penn State professor

(Date:8/1/2014)... 2014 Parker Waichman LLP, a national ... injured by defective medical devices and drugs reports that ... Ethicon surgical power morcellator devices used for the removal ... the spread of cancer associated with power morcellators, according ... 2014. , Johnson & Johnson had previously ceased ...
(Date:8/1/2014)... Aug. 1, 2014 (HealthDay News) -- Almost 140 ... school transportation in the United States. But ... bus-related catastrophes, Dawne Gardner, injury prevention coordinator at ... Center, said in a medical center news release. ... returning to school, it,s important for parents and ...
(Date:8/1/2014)... The evolving healthcare landscape presents ... At ThoughtSpot 2014, AmerisourceBergen and Good Neighbor Pharmacy’s ... resources to enhance patient care and profitability. At ... issues to give independent pharmacists the tools they ... ThoughtSpot show attendance experienced a nearly 70% increase ...
(Date:8/1/2014)... DC (PRWEB) August 01, 2014 ... Thompson (D-CA), Gregg Harper (R-MS), and Peter Welch ... 5380, the Medicare Telehealth Parity Act of 2014, ... fully support this effort to improve healthcare access ... chief executive officer of ATA. "These cost-saving provisions ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 On Monday, ... California NextGen User Symposium in San Francisco, CA. Now ... at the JW Marriott Union Square hotel. , “We ... get up to speed with ACA compliance issues,” Quirk ... month. The symposium provides attendees guidance with NextGen implementation ...
Breaking Medicine News(10 mins):Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 2Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 3Health News:J&J's Ethicon Unit Recalls its Power Morcellator Devices After Warnings by Federal Regulators and Concern About Risk of Spreading Occult Cancer, Parker Waichman Comments 4Health News:Expert Offers School Bus Safety Tips 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 2Health News:ThoughtSpot 2014 Inspires as General Session Concludes 3Health News:ThoughtSpot 2014 Inspires as General Session Concludes 4Health News:ThoughtSpot 2014 Inspires as General Session Concludes 5Health News:ATA Applauds Bill on Medicare Telemedicine Improvements 2Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2
(Date:8/1/2014)... 1, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... Phase 3 study evaluating ISIS-SMN Rx in infants ... cause of infant mortality. Isis plans to dose the ... weeks, at which time Isis will earn an $18 ... The Phase 3 study, ENDEAR, is the first of ...
(Date:8/1/2014)... Pa. , Aug. 1, 2014 Inovio ... will host a conference call to report its second ... at 9:00 AM ET. CEO Dr. J. Joseph ... discuss second quarter earnings, provide a corporate update, and ... will include clinical development plans for VGX-3100, Inovio,s immune ...
(Date:8/1/2014)... Arena Pharmaceuticals, Inc. (NASDAQ: ... reported financial results for the second quarter ended ... continued to see encouraging advancements in the US ... in estimated total prescriptions and estimated total per ... Lief, Arena,s President and Chief Executive Officer. "Other ...
Breaking Medicine Technology:Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11
Cached News: